Oncotelic Therapeutics, Inc. (OTLC) — 8-K Filings
All 8-K filings from Oncotelic Therapeutics, Inc.. Browse 11 Current Event Report reports with AI-powered summaries and risk analysis.
8-K Filings (11)
- 8-K Filing — Apr 2, 2026
- 8-K Filing — Dec 30, 2025
- 8-K Filing — Dec 23, 2025
-
Oncotelic Therapeutics Files 8-K on Agreements
— Dec 9, 2025 Risk: medium
On December 4, 2025, Oncotelic Therapeutics, Inc. filed an 8-K report detailing a material definitive agreement. The filing also covers unregistered sales of eq -
Oncotelic Therapeutics Files 8-K
— Oct 22, 2025 Risk: low
On October 21, 2025, Oncotelic Therapeutics, Inc. filed an 8-K report. The filing indicates the company is reporting on "Other Events" and "Financial Statements -
Oncotelic Therapeutics Reports Material Agreement and Equity Sales
— Aug 12, 2025 Risk: medium
On August 6, 2025, Oncotelic Therapeutics, Inc. entered into a material definitive agreement. The company also reported the creation of a direct financial oblig - 8-K Filing — Aug 6, 2025
- 8-K Filing — Mar 25, 2025
-
Oncotelic Therapeutics Files 8-K
— Jan 2, 2025 Risk: low
Oncotelic Therapeutics, Inc. filed an 8-K on January 2, 2025, reporting events as of December 31, 2024. The filing primarily concerns financial statements and e -
Oncotelic Therapeutics Files 8-K
— Apr 29, 2024 Risk: medium
Oncotelic Therapeutics, Inc. filed an 8-K on April 29, 2024, reporting an event that occurred on April 26, 2024. The filing pertains to 'Other Events' and 'Fina -
Oncotelic Sells 1M Shares at $0.001 Each in Private Placement
— Feb 2, 2024
On January 29, 2024, Oncotelic Therapeutics, Inc. entered into a material definitive agreement to issue 1,000,000 shares of its common stock at $0.001 per share
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX